2002
DOI: 10.1023/a:1015773818302
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Primitive neuroectodermal tumors (PNETs) are composed of immature neuronal precursor cells and sometimes more mature neuronal cell types. Medulloblastomas, occuring in the cerebellum, represent the most common PNET and are broadly classified into two subgroups: classical and desmoplastic. Desmoplastic medulloblastomas exhibit a slightly better prognosis than classical medulloblastomas. However, there are currently no good molecular markers available to distinguish clinical outcome and similar treatment is used… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(15 citation statements)
references
References 34 publications
0
15
0
Order By: Relevance
“…SoxC transcription factors are essential for embryonic mesenchymal progenitor survival [63]. Sox4 or Sox11 up-regulation has also been implicated in hematopoietic and non-hematopoietic malignancies [55-58, 64]. Our data are the first to link the SoxC factors to eRMS and Hh-dependent tumorigenesis.…”
Section: Discussionmentioning
confidence: 67%
“…SoxC transcription factors are essential for embryonic mesenchymal progenitor survival [63]. Sox4 or Sox11 up-regulation has also been implicated in hematopoietic and non-hematopoietic malignancies [55-58, 64]. Our data are the first to link the SoxC factors to eRMS and Hh-dependent tumorigenesis.…”
Section: Discussionmentioning
confidence: 67%
“…A downstream effector of Wnt signaling along with LEF-1, SOX4 may play a role in tumor cell differentiation. SOX4 is known to be overexpressed in MB, especially the classic variant and has been suggested as a favorable prognostic factor (Lee et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Reduction of miR-335 levels in breast cancer cells led to increased expression of SOX4, resulting in metastatic progression as a result of increased cell invasion and migration. Subsequent to its discovery as a mediator of breast cancer metastasis, SOX4 expression has been shown to be also increased in other cancer types, including leukemia (10,11), glioblastoma (12,13), medulloblastoma (14,15), hepatocellular carcinoma (HCC) (16), and prostate cancer (1719). Despite this evidence supporting the tumorigenic properties of SOX4, comparative analyses of the SOX4 transcriptional network revealed a high degree of variation between the target genes in different cancers, which suggest the tumor-specific and context-dependent mechanisms of target gene selection (20).…”
Section: Introductionmentioning
confidence: 99%